Top 50 Pharma Tracker: Pharma supported #TumorBoardTuesday is a hit for eHCPs

02.04.2024 | Tracker

Top 50 Pharma Tracker: Pharma supported #TumorBoardTuesday is a hit for eHCPs

Discover what healthcare professionals (eHCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are eHCPs responding to drug launch news? How are eHCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of eHCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by eHCPs on X

March
Rank
February
Rank
Company
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer1,7461700
22Moderna1,065416
33Johnson & Johnson7582167
44AstraZeneca6593246
56GSK52517014
612Novo Nordisk44122218
75Bayer389455
810Roche2981809
914Gilead Sciences193771
1014Lilly1871080
1111Abbott1751721
128Novavax143120
1323Daiichi Sankyo13311616
1421Boehringer Ingelheim125490
157AbbVie1211015
1613Sanofi113487
1729Fresenius107263
1819Novartis105582
1920Merck & Co103458
2017BioNTech9320
2116BMS85700
229Takeda84670
2318Amgen63424
2429Servier5986
2524Organon5400
2628Astellas48430
2725Regeneron47300
2827UCB332514
2937Ipsen30242
3032Grifols2800
3125Otsuka2772
3235Teva26181
3342Merck KGaA21207
3343Sun2110
3522Biogen2060
3631Vertex15150
3740Perrigo1310
3832Eisai1130
3834Bausch1141
4041Jazz Pharmaceuticals850
4137Viatris600
4137CSL641
4336Incyte530
4443Menarini411
4550CSPC200
4643Chugai111
4646Horizon110
5050Shanghai000
5050Sino000
5050Jiangsu Hengrui000

The latest insights from eHCPs mentioning the Top 50 Pharmaceutical Companies

The five pharmaceutical companies that were mentioned the most by eHCPs on X in March 2024 were Pfizer, Moderna, Johnson & Johnson, AstraZeneca and GSK.

CREATION.co identified 7,135 eHCP mentions of pharmaceutical companies in March 2024, 14% fewer mentions than the previous month.

On 6th March, eHCPs discussed the #TumorBoardTuesday online board that took place the previous day. The board was supported by multiple pharmaceutical companies including AstraZeneca, Janssen, and others. 

Shared by 2 eHCPs

Oncologist Rafee Talukder ran a tutorial on X for #TumorBoardTuesday. One post in particular gained traction amongst the eHCP community, where he shared an article discussing data revealed at ESMO 2023. The study was sponsored by Seagen, Astellas and Merck, and received a standing ovation at the congress.

Shared by 8 eHCPs

On 08 March, Novo Nordisk’s Wegovy received an expanded-label approval from the FDA following studies demonstrating a reduction in cardiovascular risks. Doctor Michael Gibson called this “big news” for Novo Nordisk and patients. Nine eHCPs shared his post. Doctor Mehrbod Vakhshoori responded to the post, saying this news “sounds great”.

On the 14th March, eHCPs shared an article detailing the potential of Gilead’s antiviral treatment “obeldesivir” against Ebola. The news article was shared by six eHCPs.

The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:

  1. A press release from Novo Nordisk about the FLOW trial for semaglutide.
  2. An ASCO publication discussing gilteritinib as a post-transplant treatment option for a specific type of leukaemia.
  3. A press release from BMS discussing the approval of Breyanzi as the first CAR T cell therapy for the treatment of different cancers.

CREATION.co continues to analyse online eHCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

Methodology notes:

    • In March 2024, CREATION Pinpoint® identified 7,135 posts on X (Twitter) from 3,212 individual eHCPs mentioning a Top 50 Pharmaceutical company (based on revenue). 
    • Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 – 31 March 2024.
  • Unless otherwise specified mentions of a company are not limited to its X account(s).
  • In some cases, a post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Johnson & Johnson Innovative Medicine (previously Janssen). In March 2024, 54 of these posts mentioned Johnson & Johnson Innovative Medicine or Janssen.

Share this article

Meet the Author

Aman Jandu

With a background working in IT systems administration, and leveraging a 1st Class degree in Digital Technologies, Aman uses his technical skills to apply a systematic approach to gather data and analyse insights.

Aman loves to Speedcube. While he can currently solve a Rubik’s Cube in around 20 seconds, he is learning how to complete it blindfolded.

Suggested next


02.04.2024 | Article

Product Launch Tracker: eHCPs celebrated the first approved treatment for patients with NASH

Discover which drug approvals HCPs are talking about online

By Alexandra Maria Chatziioannidou

02.06.2023 | Article

Product Launch Tracker: eHCPs are delighted with the approval of the first RSV vaccine for adults aged 60 and over.

Discover which new drug approvals HCPs are talking about

View all articles >